Farid Ramy 4
4 · Vir Biotechnology, Inc. · Filed May 31, 2024
Insider Transaction Report
Form 4
Farid Ramy
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-29+16,000→ 16,000 totalExercise: $10.10Exp: 2034-05-28→ Common Stock (16,000 underlying) - Award
Stock Option (Right to Buy)
2024-05-29+16,000→ 16,000 totalExercise: $10.10Exp: 2034-05-28→ Common Stock (16,000 underlying) - Award
Common Stock
2024-05-29+16,000→ 16,000 total
Footnotes (2)
- [F1]1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter.
- [F2]Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders.